As in previous years, Novartis will be attending the 44th Annual J.P. Morgan Healthcare Conference in San Francisco in January 2026. Here’s where you can see our senior leadership at this year’s event.
Header
J.P. Morgan Healthcare Conference 2026
San Francisco, USA
Novartis at JPM 2026 – some news and information before the event kicks off.
Novartis company presentation
Novartis CEO, Vas Narasimhan, will present the company’s growth strategy and pipeline on Monday, January 12 at 9am in the Grand Ballroom of The Westin St. Francis Conference venue.
Senior Novartis leaders speaking at JPM 2026
Executive Committee leaders will be speaking at the following organised panels – follow the links to register and attend.
Manufacturing during global policy uncertainty
Victor Bulto, President, US, will speak on the Endpoints panel on Monday, January 12 from 11:05am to 11:30am, at the Marriot Marquis.
Reshoring Pharma Production at Scale
Victor Bulto, President, US, will speak on the Fierce panel on Tuesday, January 13 from 3:40pm to 4:20pm at the Hyatt Regency.
Pharma’s Big Bets and the Resurgence of M&A
Ronny Gal, Chief Strategy & Growth Officer will speak on the Fierce panel on Tuesday, January 13 from 09:20am to 10:00am at the Hyatt Regency.
In the news
Explore some recent media coverage explaining our performance, strategy and approach to business development
Strategy
Learn about the Novartis strategy and explore our core therapeutic areas and technology platforms.
Investor Relations
We aim for sustainable performance over time to benefit patients, employees, shareholders and society. Solid financial results and maintaining the trust of society underpin our ability to create value.